Dynamic Technology Lab’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-51,203
Closed -$835K 1181
2025
Q4
$835K Sell
51,203
-45,076
-47% -$681K 0.19% 173
2025
Q3
$1.13M Buy
96,279
+57,256
+147% +$747K 0.19% 161
2025
Q2
$451K Buy
+39,023
New +$356K 0.06% 558
2024
Q4
Sell
-9,016
Closed -$204K 1363
2024
Q3
$204K Buy
+9,016
New +$186K 0.02% 870
2024
Q2
Sell
-53,367
Closed -$2M 1402
2024
Q1
$2M Buy
53,367
+42,720
+401% +$1.88M 0.21% 117
2023
Q4
$596K Buy
+10,647
New +$463K 0.06% 523
2022
Q1
Sell
-1,543
Closed -$230K 1528
2021
Q4
$230K Sell
1,543
-5,934
-79% -$909K 0.03% 908
2021
Q3
$1.09M Buy
7,477
+2,425
+48% +$416K 0.13% 246
2021
Q2
$990K Buy
+5,052
New +$914K 0.1% 331
2021
Q1
Sell
-2,228
Closed -$315K 1491
2020
Q4
$315K Buy
2,228
+427
+24% +$62K 0.05% 631
2020
Q3
$225K Buy
+1,801
New +$189K 0.04% 770

Other funds holding TXG

Dynamic Technology Lab's TXG Position: Q1 2026 in Review

Dynamic Technology Lab sold out of 10x Genomics (TXG) in Q1 2026, closing a stake of 51,203 shares — an estimated $835K sold.

Dynamic Technology Lab first reported a position in TXG in Q3 2020 and held it in 11 quarters. The position peaked at $2M in Q1 2024. 330 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Dynamic Technology Lab reported no remaining 10x Genomics position as of Q1 2026 after selling out during the quarter.
  • Dynamic Technology Lab sold 51,203 10x Genomics shares in Q1 2026, an estimated $835K.
  • Dynamic Technology Lab first reported a position in 10x Genomics in Q3 2020 and held it in 11 quarters.
  • Dynamic Technology Lab's 10x Genomics position peaked at $2M in Q1 2024.
  • 330 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Dynamic Technology Lab's 13F filing for Q1 2026, filed 15 May 2026.